Carvolix Joins Euronext Indices, Enhancing Market Profile

Carvolix, formerly known as Affluent Medical, marks a significant achievement by joining key Euronext indices. As of March 23, 2026, the company is now part of the CAC® Small, CAC® Mid & Small, and CAC® All-Tradable indices. This inclusion follows the recent quarterly review by Euronext.

The company specializes in developing advanced AI-driven mini-robots and biomimetic implants for the medical field. By being part of these indices, Carvolix aims to increase its visibility and liquidity in the market, potentially attracting index-tracking funds and expanding its investor base.

Sébastien Ladet, CEO of Carvolix, emphasizes that this development underlines the recognition of their technology and supports their mission to democratize access to complex medical procedures. The inclusion is a strategic move towards accelerating the deployment of their cutting-edge solutions for structural heart diseases and stroke treatment.